SEC Form 4 · accession 0001104659-26-075253
Zenas BioPharma, Inc. · ZBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patricia L Allen
Director
Period of report
Jun 15, 2026
Accepted (ET)
Jun 17, 2026 · 6:01 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001953926
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $18.71 | Jun 15, 2026 | A | 18,500 | A | — | Jun 15, 2036 | Common Stock | 18,500 | 18,500 | D |
Explanation of responses
- F1The option vests as to 100% of the underlying shares of common stock on June 15, 2027, the first anniversary of the vesting commencement date, subject to continued service.